Article
Development and application of ribonucleic acid therapy strategies against COVID-19
1 Jan 2022
Abstract excerpt
The Coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2), remaining a global health crisis since its outbreak until now. Advanced biotechnology and research findings have revealed many suitable viral and host targets for a wide range of therapeutic strategies. The emerging ribonucleic acid therapy can modulate gene expression by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
